Close

ORA Plans To Fund Telehealth Expansion In Southeast Asia

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

AI-Driven Medication Management: Safety and Efficiency

Integrating artificial intelligence (AI) is fundamental to the digital...

China’s AI Doctors Revolutionize Healthcare with First AI Hospital

China recently announced a ground-breaking development: the world's first...

Low-Carbon Inhalers Approved for COPD Treatment in the UK

According to AstraZeneca, the Medicines and Healthcare Products Regulatory...

Chinese Medtech Companies Reshape Healthcare by Innovation

The worldwide medtech spectrum is undergoing a phenomenal shift,...

ORA, which is one of the best telehealth platforms in Singapore, has garnered USD10M in a Series A funding round. It has set the record for the largest telehealth Series A in Southeast Asia. The round, spearheaded by TNB Aura and Antler, included contributions from Kairous Capital, Gobi Partners, and GMA Ventures, raising the total funds acquired to more than $17 million.

As the fastest-growing and largest vertically-integrated telehealth platform in Southeast Asia, ORA has conducted more than 250,000 consultations since its launch in 2021, experiencing consistent monthly growth. It has introduced three brands catering to patients with chronic conditions, focusing on accessibility, convenience, and personalization. Modules present a cutting-edge online dermatology experience, delivering personalized prescription skincare encompassing a wide range of 676 unique formulations. andSons specializes in male health solutions, while OVA focuses on female reproductive healthcare.

ORA plans to utilize its recent $10 million Series A funding to expand into new territories and introduce new offerings. In the coming months, ORA’s brands will be available in 1,300 tier-one retail stores, making their accessible and medically-backed products more widely accessible. The company also sees potential for expansion into regions such as the Gulf Cooperation Council (GCC), including Bahrain, Saudi Arabia, Oman, Kuwait, Qatar, and the United Arab Emirates.

Latest stories

Related stories

AI-Driven Medication Management: Safety and Efficiency

Integrating artificial intelligence (AI) is fundamental to the digital...

China’s AI Doctors Revolutionize Healthcare with First AI Hospital

China recently announced a ground-breaking development: the world's first...

Low-Carbon Inhalers Approved for COPD Treatment in the UK

According to AstraZeneca, the Medicines and Healthcare Products Regulatory...

Chinese Medtech Companies Reshape Healthcare by Innovation

The worldwide medtech spectrum is undergoing a phenomenal shift,...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back